Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Vs. Tacrolimus and Methotrexate As Graft-Versus-Host Disease Prevention Among Allogeneic Stem Cell Transplant Patients Receiving Myeloablative Conditioning

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Catie Cash, Erin Eberwein, Daniel P. Schrum, Elizabeth Rogers Eubanks, Joshua Burrows, Hui‐Jie Lee

DOI: 10.1016/j.jtct.2025.12.926

Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes